Log in to save to my catalogue

Irinotecan- vs. Oxaliplatin-Based Doublets in KRAS[sup.G12C]-Mutated Metastatic Colorectal Cancer—A...

Irinotecan- vs. Oxaliplatin-Based Doublets in KRAS[sup.G12C]-Mutated Metastatic Colorectal Cancer—A...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A752473851

Irinotecan- vs. Oxaliplatin-Based Doublets in KRAS[sup.G12C]-Mutated Metastatic Colorectal Cancer—A Multicentre Propensity-Score-Matched Retrospective Analysis

About this item

Full title

Irinotecan- vs. Oxaliplatin-Based Doublets in KRAS[sup.G12C]-Mutated Metastatic Colorectal Cancer—A Multicentre Propensity-Score-Matched Retrospective Analysis

Publisher

MDPI AG

Journal title

Cancers, 2023-06, Vol.15 (11)

Language

English

Formats

Publication information

Publisher

MDPI AG

More information

Scope and Contents

Contents

The sensitivity to chemotherapy of KRASG12C-mutated colorectal cancer has been investigated to verify whether the combination of chemotherapy plus a KRASG12C-inhibitor might become the standard of care in the near future. To this aim, the present retrospective study was designed to assess the performance of irinotecan vs. oxaliplatin in the first-l...

Alternative Titles

Full title

Irinotecan- vs. Oxaliplatin-Based Doublets in KRAS[sup.G12C]-Mutated Metastatic Colorectal Cancer—A Multicentre Propensity-Score-Matched Retrospective Analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A752473851

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A752473851

Other Identifiers

ISSN

2072-6694

E-ISSN

2072-6694

DOI

10.3390/cancers15113064

How to access this item